Effects of long-term magnesium supplementation on endothelial function and cardiometabolic risk markers: A randomized controlled trial in overweight/obese adults

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Joris, Peter J ^a,b   Plat, Jogchum ^a   Bakker, Stephan J L ^c   Mensink, Ronald P ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MAGNESIUM;

AGED; ARTERIAL STIFFNESS; BLOOD; BRACHIAL ARTERY; CONTROLLED STUDY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; VASODILATATION;

AGED; BIOMARKERS; BRACHIAL ARTERY; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; POSTMENOPAUSE; VASCULAR STIFFNESS; VASODILATION;

EID: 85039037180     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-00205-9     Document Type: Article

References (43)

1. Fang, X. et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a doseresponse meta-analysis of prospective cohort studies. BMC Med. 14, 210 (2016).
2. Del Gobbo, L. C. et al. Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 98, 160-173 (2013).
3. Joosten, M. M. et al. Urinary and plasma magnesium and risk of ischemic heart disease. Am. J. Clin. Nutr. 97, 1299-1306 (2013).
4. Joris, P. J., Plat, J., Bakker, S. J. & Mensink, R. P. Long-term magnesium supplementation improves arterial stiffness in overweight and obese adults: results of a randomized, double-blind, placebo-controlled intervention trial. Am. J. Clin. Nutr. 103, 1260-1266 (2016).
5. Laurent, S. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27, 2588-2605 (2006).
6. Wilkinson, I. B. et al. Nitric oxide regulates local arterial distensibility in vivo. Circulation 105, 213-217 (2002).
7. Guerrero-Romero, F. et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 30, 253-258 (2004).
8. Paolisso, G. et al. Daily magnesium supplements improve glucose handling in elderly subjects. Am. J. Clin. Nutr. 55, 1161-1167 (1992).
9. Marken, P. A. et al. Effects of magnesium oxide on the lipid profile of healthy volunteers. Atherosclerosis 77, 37-42 (1989).
10. Chacko, S. A. et al. Magnesium supplementation, metabolic and inflammatory markers, and global genomic and proteomic profiling: a randomized, double-blind, controlled, crossover trial in overweight individuals. Am. J. Clin. Nutr. 93, 463-473 (2011).
11. Cosaro, E. et al. Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 24, 1213-1220 (2014).
12. Mortazavi, M. et al. Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur. Neurol. 69, 309-316 (2013).
13. Shechter, M. et al. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 102, 2353-2358 (2000).
14. Ellins, E. A. & Halcox, J. P. Where are we heading with noninvasive clinical vascular physiology? Why and how should we assess endothelial function? Cardiol. Res. Pract 2011, 870132 (2011).
15. Poredos, P. & Jezovnik, M. K. Testing endothelial function and its clinical relevance. J. Atheroscler. Thromb 20, 1-8 (2013).
16. Deanfield, J. E., Halcox, J. P. & Rabelink, T. J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 115, 1285-1295 (2007).
17. Cohn, J. N., Quyyumi, A. A., Hollenberg, N. K. & Jamerson, K. A. Surrogate markers for cardiovascular disease: functional markers. Circulation 109, IV31-IV46 (2004).
18. Beijers, H. J. et al. Higher central fat mass and lower peripheral lean mass are independent determinants of endothelial dysfunction in the elderly: the Hoorn study. Atherosclerosis 233, 310-318 (2014).
19. Despres, J. P. & Lemieux, I. Abdominal obesity and metabolic syndrome. Nature 444, 881-887 (2006).
20. Ras, R. T., Streppel, M. T., Draijer, R. & Zock, P. L. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int. J. Cardiol. 168, 344-351 (2013).
21. Seelig, M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am. J. Cardiol. 63, 4G-21G (1989).
22. Turgut, F. et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int. Urol. Nephrol. 40, 1075-1082 (2008).
23. Lorenz, M. W. et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and metaanalysis. Circulation 115, 459-467 (2007).
24. Calder, P. C. et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br. J. Nutr. 109, S1-S34 (2013).
25. Cunha, A. R., Umbelino, B., Correia, M. L. & Neves, M. F. Magnesium and vascular changes in hypertension. Int. J. Hypertens. 2012, 754250 (2012).
26. Song, Y., He, K., Levitan, E. B., Manson, J. E. & Liu, S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet. Med 23, 1050-1056 (2006).
27. Simental-Mendia, L. E., Sahebkar, A., Rodriguez-Moran, M. & Guerrero-Romero, F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol. Res. 111, 272-282 (2016).
28. Heil, W. & Ehrhardt, V. Reference ranges for adults and children. Pre-analytical considerations in Roche Diagnostics 9th Edition (2008).
29. Moslehi, N., Vafa, M., Rahimi-Foroushani, A. & Golestan, B. Effects of oral magnesium supplementation on inflammatory markers in middle-aged overweight women. J. Res. Med. Sci. 17, 607-614 (2012).
30. van Mil, A. C. et al. Impact of volunteer-related and methodology-related factors on the reproducibility of brachial artery flowmediated vasodilation: analysis of 672 individual repeated measurements. J. Hypertens. 34, 1738-1745 (2016).
31. Maier, J. A., Malpuech-Brugere, C., Zimowska, W., Rayssiguier, Y. & Mazur, A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and trombosis. Biochim. Biophys. Acta. 1689, 13-21 (2004).
32. Maier, J. A. Endothelial cells and magnesium: implications in atherosclerosis. Clin. Sci. (Lond.) 122, 397-407 (2012).
33. Santulli, G. MicroRNAs and Endothelial (Dys) Function. J. Cell Physiol. 231, 1638-1644 (2016).
34. Sorriento, D. et al. Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo. Hypertension 60, 129-136 (2012).
35. Institute of Medicine (US). Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D, and fluoride In The National Academies, 190-249 (1997).
36. van Dis, L., Geleijnse, J. M., Verschuren, W. M. & Kromhout, D. Cardiovascular risk management of hypertension and hypercholesterolaemia in the Netherlands: from unifactorial to multifactorial approach. Neth. Heart J. 20, 320-325 (2012).
37. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 8, 499-502 (1972).
38. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
39. Stam, F. et al. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. Nephrol. Dial. Transplant. 18, 892-898 (2003).
40. Corretti, M. C. et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J. Am. Coll. Cardiol. 39, 257-265 (2002).
41. Axtell, A. L., Gomari, F. A. & Cooke, J. P. Assessing endothelial vasodilator function with the Endo-PAT 2000. J. Vis. Exp. 44, e2167 (2010).
42. Stewart, C. V., Tsai, C. L. & Roysam, B. The dual-bootstrap iterative closest point algorithm with application to retinal image registration. IEEE Trans. Med. Imaging 22, 1379-1394 (2003).
43. Hubbard, L. D. et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 106, 2269-2280 (1999).